Naghdi S, Ebrahimi I, Asgari A, Olyaei G R, Kazemnejad A, Mansouri K, Ansari N N
Rehabilitation faculty, Tehran University of Medical Sciences, Iran.
Electromyogr Clin Neurophysiol. 2007 May-Jun;47(3):187-92.
The Modified Ashworth Scale (MAS) is the most widely used clinical test for the measurement of muscle spasticity. This scale that suffers from limitations and lack of reliability and validity has recently been remodified. The aim of the present study is to investigate the criterion validity of the new Modified MAS(MMAS) in the upper limb in post-stroke hemiplegia, using the Hslope/Mslope (Hslp/Mslp) as a novel index of alpha motor neuron excitability. Prior to the validity study, the reliability of the MMAS was evaluated in 30 hemiplegic patients. The raters agreed on 23 patients (0. 76%). The MMAS had good inter-rater reliability (K= 0.63, SE = 0.11, p < 0.001) for the assessment of wrist flexors spasticity in hemiplegic patients. 12 adult patients (7 women and 5 men) with first ever stroke resulting in hemiplegia with a mean age of 58.9 +/- 11.9 years (range, 37-73) were included in the validity study. The outcome measures were the MMAS for the clinical assessment of spasticity, and the HslopelMslope and the Hmax/Mmax ratio for the electrophysiological evaluation. The results showed an increase in mean rank of Hslp / Mslp in patients with a score of 1, 2 or 3 on the MMAS. However, the difference among the groups was not significant (p > 0.05). There was also no relationship between the clinical scale of MMAS and either the traditional [Hmax / Mmax ratio (r = -0.06)] or the new index [Hslp / Mslp (r = 0.24)] of spinal excitability. This preliminary study recruited a small number of patients, and failed to confirm a linear correlation between these variables. A study with a large number of patients is suggested to clarify the outcome.
改良Ashworth量表(MAS)是测量肌肉痉挛最广泛使用的临床测试。这个存在局限性且缺乏可靠性和有效性的量表最近进行了重新修订。本研究的目的是,使用H斜率/M斜率(Hslp/Mslp)作为α运动神经元兴奋性的新指标,研究新改良MAS(MMAS)在中风后偏瘫上肢中的标准效度。在效度研究之前,对30例偏瘫患者评估了MMAS的可靠性。评估者对23例患者的评估结果一致(0.76%)。MMAS在评估偏瘫患者腕屈肌痉挛方面具有良好的评估者间信度(K = 0.63,SE = 0.11,p < 0.001)。效度研究纳入了12例首次中风导致偏瘫的成年患者(7例女性和5例男性),平均年龄为58.9±11.9岁(范围37 - 73岁)。结果指标包括用于痉挛临床评估的MMAS,以及用于电生理评估的HslopelMslope和Hmax/Mmax比值。结果显示,MMAS评分为1、2或3分的患者中,Hslp / Mslp的平均秩次增加。然而,组间差异不显著(p > 0.05)。MMAS临床量表与传统的脊髓兴奋性指标[Hmax / Mmax比值(r = -0.06)]或新指标[Hslp / Mslp(r = 0.24)]之间也没有关系。这项初步研究纳入的患者数量较少,未能证实这些变量之间的线性相关性。建议进行一项纳入大量患者的研究以明确结果。